Clinical Trial Update: A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This is a Phase 3 long-term extension trial of the investigational drug TLL-018 for rheumatoid arthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TLL-018

Snippet

Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 3 | Status: RECRUITING